EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

NF‐κB/NLRP3 inflammasome axis and risk of Parkinson's disease in Type 2 diabetes mellitus: A narrative review and new perspective

Mohammed Alrouji, Hayder M Al-Kuraishy, Ali I Al-Gareeb, Athanasios Alexiou iD, Marios Papadakis, Majid S Jabir, Hebatallah M Saad iD, Gaber El-Saber Batiha

Journal of Cellular and Molecular Medicine · 2023

DOI: 10.1111/jcmm.17784 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Cellular and Molecular Medicine, 2023. Verfasst von Mohammed Alrouji und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Shaqra University, Shaqra, Saudi Arabia. Hauptthemen laut MEDLINE: Parkinson Disease, Neurodegenerative Diseases, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 85-mal zitiert (Crossref) und nennt 150 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson's disease (PD) is the second most common neurodegenerative disease after Alzheimer's disease (AD). Genetic predisposition and immune dysfunction are involved in the pathogenesis of PD. Notably, peripheral inflammatory disorders and neuroinflammation are associated with PD neuropathology. Type 2 diabetes mellitus (T2DM) is associated with inflammatory disorders due to hyperglycaemia‐induced oxidative stress and the release of pro‐inflammatory cytokines. Particularly, insulin resistance (IR) in T2DM promotes the degeneration of dopaminergic neurons in the substantia nigra (SN). Thus, T2DM‐induced inflammatory disorders predispose to the development and progression of PD, and their targeting may reduce PD risk in T2DM. Therefore, this narrative review aims to find the potential link between T2DM and PD by investigating the role of inflammatory signalling pathways, mainly the nuclear factor kappa B (NF‐κB) and the nod‐like receptor pyrin 3 (NLRP3) inflammasome. NF‐κB is implicated in the pathogenesis of T2DM, and activation of NF‐κB with induction of neuronal apoptosis was also confirmed in PD patients. Systemic activation of NLRP3 inflammasome promotes the accumulation of α‐synuclein and degeneration of dopaminergic neurons in the SN. Increasing α‐synuclein in PD patients enhances NLRP3 inflammasome activation and the release of interleukin (IL)‐1β followed by the development of systemic inflammation and neuroinflammation. In conclusion, activation of the NF‐κB/NLRP3 inflammasome axis in T2DM patients could be the causal pathway in the development of PD. The inflammatory mechanisms triggered by activated NLRP3 inflammasome lead to pancreatic β‐cell dysfunction and the development of T2DM. Therefore, attenuation of inflammatory changes by inhibiting the NF‐κB/NLRP3 inflammasome axis in the early T2DM may reduce future PD risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseNeurodegenerative DiseasesDiabetes Mellitus, Type 2HumansInflammasomesNF-kappa BNLR Family, Pyrin Domain-Containing 3 Proteinalpha-SynucleinPyrinNLR ProteinsNeuroinflammatory Diseases

Stichwörter der Autor:innen

NF-κBNLRP3 inflammasomeParkinson diseaseT2DM

Substanzen

InflammasomesNF-kappa BNLR Family, Pyrin Domain-Containing 3 Proteinalpha-SynucleinPyrinNLR Proteins

Autor:innen und Institutionen

  • Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Shaqra University, Shaqra, Saudi Arabia.
  • Department of Clinical Pharmacology and Medicine, College of Medicine, ALmustansiriyia University, Baghdad, Iraq.
  • Department of Science and Engineering, Novel Global Community Educational Foundation, Hebersham, New South Wales, Australia.
  • AFNP Med, Wien, Austria.
  • Department of Surgery II, University Hospital Witten-Herdecke, University of Witten-Herdecke, Wuppertal, Germany.
  • Applied Science Department, University of Technology, Baghdad, Iraq.

ORCID-Profile: Athanasios Alexiou, Hebatallah M Saad

Zitieren

APA

Alrouji, M., Al-Kuraishy, H. M., Al-Gareeb, A. I., Alexiou, A., Papadakis, M., Jabir, M. S., Saad, H. M., & Batiha, G. E. (2023). NF‐κB/NLRP3 inflammasome axis and risk of Parkinson's disease in Type 2 diabetes mellitus: A narrative review and new perspective. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.17784

Vancouver

Alrouji M, Al-Kuraishy HM, Al-Gareeb AI, Alexiou A, Papadakis M, Jabir MS, et al. NF‐κB/NLRP3 inflammasome axis and risk of Parkinson's disease in Type 2 diabetes mellitus: A narrative review and new perspective. Journal of Cellular and Molecular Medicine. 2023. doi:10.1111/jcmm.17784

BibTeX
@article{Alrouji2023,
  author = {Alrouji, Mohammed and Al-Kuraishy, Hayder M and Al-Gareeb, Ali I and Alexiou, Athanasios and Papadakis, Marios and Jabir, Majid S and Saad, Hebatallah M and Batiha, Gaber El-Saber},
  title = {NF‐κB/NLRP3 inflammasome axis and risk of Parkinson's disease in Type 2 diabetes mellitus: A narrative review and new perspective},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2023},
  doi = {10.1111/jcmm.17784}
}
Kostenlos starten →